##fileformat=VCFv4.2
##fileDate=2024-01-29
##reference=GRCh38
##INFO=<ID=bayesdel,Number=1,Type=String,Description="Missense variant functional predictions by BayesDel tool (Feng 2017) used without allele frequency. Score bigger or equal to 0.16: damaging; Score smaller than 0.16: tolerated. Scores were imported from dbNSFP. (version: 4.4, version date: 2023-05-06 )">
##INFO=<ID=cadd_scaled,Number=1,Type=String,Description="The scaled CADD scores: PHRED-like (-10*log10(rank/total)) scaled C-score ranking a variant relative to all possible substitutions of the human genome (8.6x10^9). These scores range from 1 to 99. A cutoff for deleteriousness can be set to 10-15, but the choice remains arbitrary. (version: v1.6, version date: 2020-04-11 )">
##INFO=<ID=cancerhotspots_ac,Number=1,Type=String,Description="Number of samples showing the variant from cancerhotspots (version: v2, version date: 2017-12-15 )">
##INFO=<ID=cancerhotspots_af,Number=1,Type=String,Description="Allele Frequency of the variant (AC / num samples cancerhotspots) (version: v2, version date: 2017-12-15 )">
##INFO=<ID=cancerhotspots_cancertypes,Number=1,Type=String,Description="A | delimited list of all cancertypes associated to this variant according to cancerhotspots. FORMAT: tumortype:tissue (version: v2, version date: 2017-12-15 )">
##INFO=<ID=clinvar,Number=1,Type=String,Description="The Variation ID from ClinVar (version: -, version date: 2023-02-26 )">
##INFO=<ID=clinvar_submissions,Number=.,Type=String,Description="An & separated list of clinvar submissions. Format:interpretation|last_evaluated|review_status|submission_condition|submitter|comment">
##INFO=<ID=clinvar_summary,Number=.,Type=String,Description="summary of the clinvar submissions. FORMAT: review_status:interpretation_summary">
##INFO=<ID=consequences,Number=.,Type=String,Description="An & separated list of variant consequences from vep. Format:Transcript|hgvsc|hgvsp,consequence|impact|exonnr|intronnr|genesymbol|proteindomain|isgencodebasic|ismaneselect|ismaneplusclinical|isensemblcanonical|transcript_biotype|transcript_length">
##INFO=<ID=cosmic,Number=1,Type=String,Description="The COSV ID from COSMIC (version: -, version date: 2023-06-06 )">
##INFO=<ID=gnomad_ac,Number=1,Type=String,Description="gnomAD alternate allele count for samples (version: v3.1.2, version date: 2021-10-22 )">
##INFO=<ID=gnomad_af,Number=1,Type=String,Description="gnomAD frequency of alternate allele in samples (version: v3.1.2, version date: 2021-10-22 )">
##INFO=<ID=gnomad_het,Number=1,Type=String,Description="gnomAD number of heterozygous individuals in samples (version: v3.1.2, version date: 2021-10-22 )">
##INFO=<ID=gnomad_hom,Number=1,Type=String,Description="gnomAD number of homozygous individuals in samples (version: v3.1.2, version date: 2021-10-22 )">
##INFO=<ID=gnomad_popmax,Number=1,Type=String,Description="gnomAD population with maximum allele frequency (AF) (version: v3.1.2, version date: 2021-10-22 )">
##INFO=<ID=gnomad_popmax_AC,Number=1,Type=String,Description="The allele count from the popmax population from GnomAD (version: v3.1.2, version date: 2021-10-22 )">
##INFO=<ID=gnomad_popmax_AF,Number=1,Type=String,Description="The allele frequency of the "popmax" population (version: v3.1.2, version date: 2021-10-22 )">
##INFO=<ID=heredicare_annotation,Number=.,Type=String,Description="An & separated list of the variant annotations from heredicare. Format:vid|n_fam|n_pat|vustf_selected_class|vustf_comment|vustf_classification_date. n_fam is the number of families having the variant and n_pat is the number of individuals having the variant.">
##INFO=<ID=heredicare_vid,Number=1,Type=String,Description="The VID from HerediCare.The version_date is inaccurate. They are always up to date when reimporting from heredicare. (version: -, version date: 2023-01-01 )">
##INFO=<ID=hexplorer,Number=1,Type=String,Description="The HEXplorer delta score (HZEI mutant - HZEI wildtype). HZEI scores were normalized by the total number of nucleotide positions which contribute to the score. (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=hexplorer_mut,Number=1,Type=String,Description="The HEXplorer score for the mutant sequence. HZEI scores were normalized by the total number of nucleotide positions which contribute to the score. (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=hexplorer_rev,Number=1,Type=String,Description="The HEXplorer delta score for the reverse complement of the original sequence (HZEI mutant rev - HZEI wildtype rev). HZEI scores were normalized by the total number of nucleotide positions which contribute to the score. (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=hexplorer_rev_mut,Number=1,Type=String,Description="The HEXplorer score for the reverse complement of the mutant sequence. HZEI scores were normalized by the total number of nucleotide positions which contribute to the score. (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=hexplorer_rev_wt,Number=1,Type=String,Description="The HEXplorer score for the reverse complement of the reference sequence. HZEI scores were normalized by the total number of nucleotide positions which contribute to the score. (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=hexplorer_wt,Number=1,Type=String,Description="The HEXplorer score for the reference sequence. HZEI scores were normalized by the total number of nucleotide positions which contribute to the score. (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=max_hbond,Number=1,Type=String,Description="The HBond delta score (max HBond mutant - max HBond wildtype). This score shows the change in binding affinity of the U1 snRNA to the splice site motiv, i. e. its ability to form hbonds with the sequence motiv. Negative values show that the mutant sequence is less probable to bind the U1 snRNA (This is a "worse" binding site). Positive values mean that the mutant sequence is more likely to bind the U1 snRNA. If there are multiple possible splice sites only the max values are considered. (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=max_hbond_mut,Number=1,Type=String,Description="The max HBond score for the mutant sequence.  (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=max_hbond_wt,Number=1,Type=String,Description="This is the max HBond score for the reference sequence. (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=maxentscan_swa,Number=1,Type=String,Description="The transcript specific MaxEntScan SWA scores calculated from ngs-bits. A special application of the MaxEntScan algorithm to discover de-novo spliceing variants. Each value is of the form maxentscan_ref_donor|maxentscan_alt_donor|maxentscan_donor_comp|maxentscan_ref_acceptor|maxentscan_alt_acceptor|maxentscan_acceptor_comp. A | separated list of transcript$value pairs. (version: v1.0.0, version date: 2023-09-27 )">
##INFO=<ID=phylop_100way,Number=1,Type=String,Description="PhyloP 100 vertebrates (100-way) conservation scores. These scores measure evolutionary conservation at individual alignment sites. Interpretations of the scores are compared to the evolution that is expected under neutral drift. Positive scores: Measure conservation, which is slower evolution than expected, at sites that are predicted to be conserved. Negative scores: Measure acceleration, which is faster evolution than expected, at sites that are predicted to be fast-evolving.  (version: -, version date: 2013-12-01 )">
##INFO=<ID=pubmed,Number=.,Type=String,Description="An & separated list of pubmed ids relevant for this variant.">
##INFO=<ID=revel,Number=1,Type=String,Description="The REVEL pathogenicity score of this variant. This score can range from 0 to 1, which reflects the number of trees in the random forest that classified the variant as pathogenic. Thus, higher values represent a more "certain" decision. When choosing a cutoff one should keep in mind that higher cutoffs will result in a higher specificity, but lower sensitivity.. A | separated list of transcript$value pairs. (version: v1.3, version date: 2021-05-03 )">
##INFO=<ID=rsid,Number=1,Type=String,Description="The rs-number of a variant from dbSNP (version summary: https://www.ncbi.nlm.nih.gov/projects/SNP/snp_summary.cgi) (version: 155, version date: 2021-06-16 )">
##INFO=<ID=spliceai_details,Number=1,Type=String,Description="Details about the SpliceAI predictions: These include delta scores (DS) and delta positions (DP) for acceptor gain (AG), acceptor loss (AL), donor gain (DG), and donor loss (DL). Format: GENE|DS_AG|DS_AL|DS_DG|DS_DL|DP_AG|DP_AL|DP_DG|DP_DL (version: v1.3.1, version date: 2021-09-07 )">
##INFO=<ID=spliceai_max_delta,Number=1,Type=String,Description="Max of delta scores for acceptor gain, acceptor loss, donor gain and donor loss. A value of 0.5 or more can be assumed to have an impact on splicing. (version: v1.3.1, version date: 2021-09-07 )">
##INFO=<ID=task_force_protein_domain,Number=1,Type=String,Description="The description of the protein domain from a hand-crafted table by the VUS-Task-Force. (version: -, version date: 2022-06-01 )">
##INFO=<ID=task_force_protein_domain_source,Number=1,Type=String,Description="The source of the task force protein domain. (version: -, version date: 2022-06-01 )">
##INFO=<ID=tp53db_DNE_LOF_class,Number=1,Type=String,Description="Functional classification for loss of growth-suppression and dominant-negative activities based on Z-scores (version: r20, version date: 2019-07-01 )">
##INFO=<ID=tp53db_DNE_class,Number=1,Type=String,Description="Dominant-negative effect on transactivation by wild-type p53. Yes: dominant-negative activity on WAF1 and RGC promoters, Moderate: dominant-negative activity on some but not all promoters, No: no dominant-negative activity on both WAF1 and RGC promoters, or none of the promoters in the large studies. (version: r20, version date: 2019-07-01 )">
##INFO=<ID=tp53db_bayes_del,Number=1,Type=String,Description="Missense variant functional predictions by BayesDel tool (Feng 2017) used without allele frequency. Score bigger or equal to 0.16: damaging; Score smaller than 0.16: tolerated (version: r20, version date: 2019-07-01 )">
##INFO=<ID=tp53db_class,Number=1,Type=String,Description="Family classification: LFS = strict clinical definition of Li-Fraumeni syndrome, LFL = Li-Fraumeni like for the extended clinical definition of Li-Fraumeni, FH: family history of cancer which does not fulfil LFS or any of the LFL definitions, No FH: no family history of cancer, FH= Family history of cancer (not fulfilling the definition of LFS/LFL),  No= no family history of cancer, ?= unknown (version: r20, version date: 2019-07-01 )">
##INFO=<ID=tp53db_domain_function,Number=1,Type=String,Description="Function of the domain in which the mutated residue is located. (version: r20, version date: 2019-07-01 )">
##INFO=<ID=tp53db_transactivation_class,Number=1,Type=String,Description="Functional classification based on the overall transcriptional activity (version: r20, version date: 2019-07-01 )">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO
chr17	7674229	10286	C	T	.	.	phylop_100way=7.905;cadd_scaled=26.6;revel=ENST00000269305$0.974|ENST00000359597$0.974|ENST00000396473$0.974|ENST00000413465$0.974|ENST00000420246$0.974|ENST00000445888$0.974|ENST00000455263$0.974|ENST00000509690$0.974|ENST00000514944$0.974|ENST00000545858$0.974;spliceai_details=TP53%7C0.00%7C0.00%7C0.00%7C0.00%7C14%7C-1%7C-48%7C22;spliceai_max_delta=0.0;maxentscan_swa=ENST00000269305$-0.29%7C-7.17%7C-5.13%7C-6.45%7C-6.57%7C-6.69|ENST00000359597$-0.29%7C-7.17%7C-5.13%7C-6.45%7C-6.57%7C-6.69|ENST00000413465$-0.29%7C-7.17%7C-5.13%7C-6.45%7C-6.57%7C-6.69|ENST00000420246$-0.29%7C-7.17%7C-5.13%7C-6.45%7C-6.57%7C-6.69|ENST00000445888$-0.29%7C-7.17%7C-5.13%7C-6.45%7C-6.57%7C-6.69|ENST00000455263$-0.29%7C-7.17%7C-5.13%7C-6.45%7C-6.57%7C-6.69|ENST00000504290$-0.29%7C-7.17%7C-5.13%7C-6.45%7C-6.57%7C-6.69|ENST00000504937$-0.29%7C-7.17%7C-5.13%7C-6.45%7C-6.57%7C-6.69|ENST00000510385$-0.29%7C-7.17%7C-5.13%7C-6.45%7C-6.57%7C-6.69|ENST00000604348$-0.29%7C-7.17%7C-5.13%7C-6.45%7C-6.57%7C-6.69|ENST00000610292$-0.29%7C-7.17%7C-5.13%7C-6.45%7C-6.57%7C-6.69|ENST00000610538$-0.29%7C-7.17%7C-5.13%7C-6.45%7C-6.57%7C-6.69|ENST00000610623$-0.29%7C-7.17%7C-5.13%7C-6.45%7C-6.57%7C-6.69|ENST00000618944$-0.29%7C-7.17%7C-5.13%7C-6.45%7C-6.57%7C-6.69|ENST00000619186$-0.29%7C-7.17%7C-5.13%7C-6.45%7C-6.57%7C-6.69|ENST00000619485$-0.29%7C-7.17%7C-5.13%7C-6.45%7C-6.57%7C-6.69|ENST00000620739$-0.29%7C-7.17%7C-5.13%7C-6.45%7C-6.57%7C-6.69|ENST00000622645$-0.29%7C-7.17%7C-5.13%7C-6.45%7C-6.57%7C-6.69;gnomad_ac=1;gnomad_af=6.57938e-06;gnomad_hom=0;gnomad_het=1;gnomad_popmax=SAS;gnomad_popmax_AF=0.000207469;gnomad_popmax_AC=1;cancerhotspots_cancertypes=PANCREATICADENOCARCINOMA:pancreas%7CProstate_Adenocarcinoma:prostate%7CPancreatic_Adenocarcinoma:pancreas%7CSTOMACHADENOCARCINOMA:esophagusstomach%7CESOPHAGEALADENOCARCINOMA:esophagusstomach%7CHigh-Grade_Serous_Ovarian_Cancer:ovaryfallopiantube%7CCOLONADENOCARCINOMA:bowel%7CUTERINEMIXEDENDOMETRIALCARCINOMA:uterus%7CHIGH-GRADESEROUSOVARIANCANCER:ovaryfallopiantube%7CLUNGADENOCARCINOMA:lung%7CColorectal_Adenocarcinoma:bowel%7CLung_Adenocarcinoma:lung%7CSWEATGLANDADENOCARCINOMA:skin%7CNON-SMALLCELLLUNGCANCER:lung%7CRENALCLEARCELLCARCINOMA:kidney%7CRenal_Clear_Cell_Carcinoma:kidney%7CUTERINECARCINOSARCOMA/UTERINEMALIGNANTMIXEDMULLERIANTUMOR:uterus%7CUterine_Carcinosarcoma/Uterine_Malignant_Mixed_Mullerian_Tumor:uterus%7CHead_and_Neck_Squamous_Cell_Carcinoma:headandneck%7CLow-Grade_Glioma:cnsbrain%7COROPHARYNXSQUAMOUSCELLCARCINOMA:headandneck%7CHepatocellular_Carcinoma:liver%7CInvasive_Breast_Carcinoma:breast%7CPROSTATEADENOCARCINOMA:prostate%7CSMALLBOWELCANCER:bowel%7CGALLBLADDERCANCER:biliarytract%7CEsophageal_Adenocarcinoma:esophagusstomach%7CBladder_Urothelial_Carcinoma:bladder%7CAMPULLARYCARCINOMA:ampullaofvater%7CBREASTINVASIVEDUCTALCARCINOMA:breast;cancerhotspots_ac=50;cancerhotspots_af=0.0020629615876552377;tp53db_class=LFS%26Other;tp53db_DNE_LOF_class=unclass.;tp53db_bayes_del=0.5986;tp53db_DNE_class=Yes;tp53db_domain_function=DNA_binding;tp53db_transactivation_class=non-functional;task_force_protein_domain=DNA_binding_region_;task_force_protein_domain_source=BWRL;hexplorer=-1.11;hexplorer_mut=1.12;hexplorer_wt=2.24;hexplorer_rev=3.83;hexplorer_rev_mut=6.34;hexplorer_rev_wt=2.51;max_hbond=0.00;max_hbond_mut=8.20;max_hbond_wt=8.20;bayesdel=0.598556;rsid=121912656;clinvar=12355;heredicare_vid=18436808;cosmic=COSV53636745;clinvar_summary=criteria_provided,_multiple_submitters,_no_conflicts:Pathogenic/Likely_pathogenic;clinvar_submissions=Likely_pathogenic|2021-02-01|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Color_Diagnostics,_LLC_DBA_Color_Health|description:_This_missense_variant_replaces_glycine_with_aspartic_acid_at_codon_245_in_the_DNA_binding_domain_of_the_TP53_protein._Computational_prediction_suggests_that_this_variant_may_have_deleterious_impact_on_protein_structure_and_function_(internally_defined_REVEL_score_threshold_>%1Y_0.7,_PMID:_27666373)._Functional_studies_have_shown_the_mutant_protein_to_be_non-functional_in_DNA_binding_assay_(PMID:_20128691),_transactivation_assay_(IARC_database_and_PMID:_12826609,_21343334)_and_human_cell_proliferation_assay_(PMID:_29979965)._This_variant_has_been_reported_to_segregate_with_disease_in_4_individuals_from_a_family_affected_with_Li-Fraumeni_syndrome_(PMID:_2259385)_and_has_been_observed_in_an_individual_affected_with_early-onset_and_familial_breast_cancer_meeting_the_Chompret_criteria_for_Li-Fraumeni_syndrome_(PMID:_30482293)._This_variant_has_been_identified_in_1/251464_chromosomes_in_the_general_population_by_the_Genome_Aggregation_Database_(gnomAD)._Different_missense_variants_occurring_at_the_same_amino_acid_position,_p.Gly245Ser_and_p.Gly245Val,_are_known_to_be_disease-causing_(ClinVar_variation_ID:_12365,_376603),_indicating_that_glycine_at_this_position_is_important_for_TP53_protein_function._Based_on_the_available_evidence,_this_variant_is_classified_as_Likely_Pathogenic.&Likely_pathogenic|2016-05-31|no_assertion_criteria_provided|C0279680:Transitional_cell_carcinoma_of_the_bladder|Database_of_Curated_Mutations_(DoCM)|None&Pathogenic|2023-03-31|criteria_provided,_single_submitter|C3661900:not_provided|GeneDx|description:_Published_functional_studies_demonstrate_a_damaging_effect:_non-functional_transactivation,_aberrant_DNA_binding,_and_dominant-negative_effect_(Kato_et_al.,_2003%3B_Dearth_et_al.,_2007%3B_Malcikova_et_al.,_2010%3B_Monti_et_al.,_2011%3B_Kotler_et_al.,_2018)%3B_Not_observed_at_significant_frequency_in_large_population_cohorts_(gnomAD)%3B_In_silico_analysis_supports_that_this_missense_variant_has_a_deleterious_effect_on_protein_structure/function%3B_This_variant_is_associated_with_the_following_publications:_(PMID:_21232794,_24590827,_27696251,_23531339,_23967324,_25980754,_20128691,_21343334,_25119136,_25634208,_22052707,_18656689,_17764544,_26900293,_12826609,_17606709,_27323394,_24449472,_25860607,_26066407,_23965983,_8633021,_22803791,_24651012,_9667734,_8794843,_16861262,_24763289,_8586466,_27346245,_29752319,_31105275,_30482293,_30840781,_30720243,_34949788,_29979965,_15510160,_30224644,_2259385)&Likely_pathogenic|2016-05-31|no_assertion_criteria_provided|C0281361:Pancreatic_adenocarcinoma|Database_of_Curated_Mutations_(DoCM)|None&Likely_pathogenic|2018-12-01|no_assertion_criteria_provided|C0919267:Neoplasm_of_ovary|German_Consortium_for_Hereditary_Breast_and_Ovarian_Cancer,_University_Hospital_Cologne|None&Likely_pathogenic|2016-05-31|no_assertion_criteria_provided|C1458155:Breast_neoplasm|Database_of_Curated_Mutations_(DoCM)|None&Likely_pathogenic|2016-05-31|no_assertion_criteria_provided|C0677865:Brainstem_glioma|Database_of_Curated_Mutations_(DoCM)|None&Likely_pathogenic|2016-05-31|no_assertion_criteria_provided|C1168401:Squamous_cell_carcinoma_of_the_head_and_neck|Database_of_Curated_Mutations_(DoCM)|None&Likely_pathogenic|2016-05-31|no_assertion_criteria_provided|C0149782:Squamous_cell_lung_carcinoma|Database_of_Curated_Mutations_(DoCM)|None&Likely_pathogenic|2016-05-31|no_assertion_criteria_provided|C0279663:Ovarian_serous_cystadenocarcinoma|Database_of_Curated_Mutations_(DoCM)|None&Likely_pathogenic|2016-05-31|no_assertion_criteria_provided|C0017636:Glioblastoma|Database_of_Curated_Mutations_(DoCM)|None&Pathogenic|2022-08-31|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Ambry_Genetics|description:_The_p.G245D_mutation_(also_known_as_c.734G>A),_located_in_coding_exon_6_of_the_TP53_gene,_results_from_a_G_to_A_substitution_at_nucleotide_position_734._The_glycine_at_codon_245_is_replaced_by_aspartic_acid,_an_amino_acid_with_similar_properties._This_mutation_was_initially_described_in_a_classic_Li-Fraumeni_syndrome_(LFS)_family_in_which_the_mutation_segregated_with_disease_(Srivastava_S_et_al._Nature._348(6303):747-9)._This_alteration_is_in_the_DNA_binding_domain_of_the_TP53_protein_and_is_reported_to_have_loss_of_transactivation_capacity,_a_dominant_negative_effect_in_yeast-based_assays,_decreased_DNA_binding_activity_to_several_responsive_elements,_and_is_predicted_to_affect_several_p53_isoforms_(IARC_TP53_database%3B_Kato_S_et_al._Proc_Natl_Acad_Sci_USA._2003_Jul_8%3B100(14):8424-9%3B_Monti_P_et_al._Clin_Cancer_Res._2007_Jul_1%3B13(13):3789-95%3B_Malcikova_J_et_al._Biol_Chem._2010_Feb-Mar%3B391(2-3):197-205%3B_Monti_P_et_al._Mol_Cancer_Res._2011_Mar%3B_9(3):271-9)._Studies_conducted_in_human_cell_lines_indicate_this_alteration_is_deficient_at_growth_suppression_and_has_a_dominant_negative_effect_(Kotler_E_et_al._Mol.Cell._2018_Jul%3B71:178-190.e8%3B_Giacomelli_AO_et_al._Nat._Genet._2018_Oct%3B50:1381-1387)._This_alteration_has_been_observed_numerous_times_as_a_somatic_mutation_in_the_cancerhotspots.org_database_(Chang_MT_et_al._Cancer_Discov._2018_02%3B8:174-183)._This_variant_has_been_detected_in_at_least_one_individual_at_an_allele_fraction_that_is_suggestive_of_clonal_hematopoiesis,_a_predictor_of_TP53_pathogenicity_(Ambry_internal_data%3B_Fortuno_C_et_al._Genet_Med._2022_03%3B24:673-680)._This_amino_acid_position_is_highly_conserved_in_available_vertebrate_species._In_addition,_this_alteration_is_predicted_to_be_deleterious_by_in_silico_analysis._Based_on_the_available_evidence,_p.G245D_is_classified_as_a_pathogenic_mutation.&Likely_pathogenic|2016-05-31|no_assertion_criteria_provided|C0007112:Prostate_adenocarcinoma|Database_of_Curated_Mutations_(DoCM)|None&Likely_pathogenic|2022-06-18|criteria_provided,_single_submitter|C1835398:Li-Fraumeni_syndrome_1|Genome-Nilou_Lab|None&Likely_pathogenic|2016-05-31|no_assertion_criteria_provided|C0278701:Gastric_adenocarcinoma|Database_of_Curated_Mutations_(DoCM)|None&Likely_pathogenic|2016-05-31|no_assertion_criteria_provided|C2239176:Hepatocellular_carcinoma|Database_of_Curated_Mutations_(DoCM)|None&Likely_pathogenic|2016-05-31|no_assertion_criteria_provided|C0280630:Uterine_carcinosarcoma|Database_of_Curated_Mutations_(DoCM)|None&Likely_pathogenic|2016-05-31|no_assertion_criteria_provided|C0009404:Neoplasm_of_the_large_intestine|Database_of_Curated_Mutations_(DoCM)|None&Likely_pathogenic|2016-05-31|no_assertion_criteria_provided|C0006118:Neoplasm_of_brain|Database_of_Curated_Mutations_(DoCM)|None&Likely_pathogenic|2016-05-31|no_assertion_criteria_provided|C0152018:Esophageal_carcinoma|Database_of_Curated_Mutations_(DoCM)|None&Pathogenic|2022-08-27|criteria_provided,_single_submitter|C0085390:Li-Fraumeni_syndrome|Invitae|description:_This_sequence_change_replaces_glycine,_which_is_neutral_and_non-polar,_with_aspartic_acid,_which_is_acidic_and_polar,_at_codon_245_of_the_TP53_protein_(p.Gly245Asp)._The_frequency_data_for_this_variant_in_the_population_databases_is_considered_unreliable,_as_metrics_indicate_poor_data_quality_at_this_position_in_the_gnomAD_database._This_missense_change_has_been_observed_in_individual(s)_with_chronic_lymphocytic_leukemia_and_chronic-phase_primary_myelofibrosis_and_Li_Fraumeni_syndrome-associated_cancers_(PMID:_2259385,_21232794,_22052707)._It_has_also_been_observed_to_segregate_with_disease_in_related_individuals._ClinVar_contains_an_entry_for_this_variant_(Variation_ID:_12355)._Advanced_modeling_of_experimental_studies_(such_as_gene_expression,_population_dynamics,_functional_pathways,_and_cell-cycle_effects_in_cell_culture)_performed_at_Invitae_indicates_that_this_missense_variant_is_expected_to_disrupt_TP53_protein_function._Experimental_studies_have_shown_that_this_missense_change_affects_TP53_function_(PMID:_12826609,_17606709,_20128691,_25119136,_29979965)._This_variant_disrupts_the_p.Gly245_amino_acid_residue_in_TP53._Other_variant(s)_that_disrupt_this_residue_have_been_determined_to_be_pathogenic_(PMID:_1565143,_1591732,_7783166,_12826609,_12885464,_23538418)._This_suggests_that_this_residue_is_clinically_significant,_and_that_variants_that_disrupt_this_residue_are_likely_to_be_disease-causing._For_these_reasons,_this_variant_has_been_classified_as_Pathogenic.&Likely_pathogenic|2016-05-31|no_assertion_criteria_provided|C0152013:Lung_adenocarcinoma|Database_of_Curated_Mutations_(DoCM)|None&Pathogenic|1990-12-20|no_assertion_criteria_provided|C1835398:Li-Fraumeni_syndrome_1|OMIM|None&Likely_pathogenic|2019-03-26|criteria_provided,_single_submitter|C3661900:not_provided|Quest_Diagnostics_Nichols_Institute_San_Juan_Capistrano|description:_The_best_available_variant_frequency_is_uninformative._Found_in_at_least_one_symptomatic_patient._Predicted_to_have_a_damaging_effect_on_the_protein._Two_other_pathogenic_or_likely_pathogenic_variants_affect_the_same_amino_acid._Assessment_of_experimental_evidence_suggests_this_variant_results_in_abnormal_protein_function._Inconclusive_segregation_with_disease.&Likely_pathogenic|2022-06-18|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Genome-Nilou_Lab|None;heredicare_annotation=18436808|12|12|||;consequences=ENST00000269305|c.734G>A|p.Gly245Asp|missense_variant|moderate|7|None|TP53|PF00870|True|True|False|True|protein_coding|1172&ENST00000359597|c.734G>A|p.Gly245Asp|missense_variant|moderate|6|None|TP53|PF00870|True|False|False|False|protein_coding|1023&ENST00000413465|c.734G>A|p.Gly245Asp|missense_variant|moderate|6|None|TP53|PF00870|True|False|False|False|protein_coding|851&ENST00000420246|c.734G>A|p.Gly245Asp|missense_variant|moderate|7|None|TP53|PF00870|True|False|False|False|protein_coding|1017&ENST00000445888|c.734G>A|p.Gly245Asp|missense_variant|moderate|7|None|TP53|PF00870|True|False|False|False|protein_coding|1172&ENST00000455263|c.734G>A|p.Gly245Asp|missense_variant|moderate|7|None|TP53|PF00870|True|False|False|False|protein_coding|1032&ENST00000503591|None|None|downstream_gene_variant|modifier|None|None|TP53|None|False|False|False|False|protein_coding|1172&ENST00000504290|c.338G>A|p.Gly113Asp|missense_variant|moderate|3|None|TP53|PF00870|True|False|False|False|protein_coding|639&ENST00000504937|c.338G>A|p.Gly113Asp|missense_variant|moderate|3|None|TP53|PF00870|True|False|False|False|protein_coding|779&ENST00000505014|None|None|downstream_gene_variant|modifier|None|None|TP53|None|False|False|False|False|retained_intron|1256&ENST00000508793|None|None|downstream_gene_variant|modifier|None|None|TP53|None|False|False|False|False|protein_coding|1172&ENST00000509690|c.338G>A|p.Gly113Asp|missense_variant|moderate|4|None|TP53|PF00870|False|False|False|False|protein_coding|779&ENST00000510385|c.338G>A|p.Gly113Asp|missense_variant|moderate|3|None|TP53|PF00870|True|False|False|False|protein_coding|624&ENST00000514944|c.455G>A|p.Gly152Asp|missense_variant|moderate|6|None|TP53|PF00870|False|False|False|False|protein_coding|894&ENST00000574684|None|None|downstream_gene_variant|modifier|None|None|TP53|None|False|False|False|False|protein_coding_CDS_not_defined|102&ENST00000576024|None|None|upstream_gene_variant|modifier|None|None|TP53|None|False|False|False|False|protein_coding|93&ENST00000604348|None|None|downstream_gene_variant|modifier|None|None|TP53|None|True|False|False|False|protein_coding|1151&ENST00000610292|c.617G>A|p.Gly206Asp|missense_variant|moderate|6|None|TP53|PF00870|True|False|False|False|protein_coding|1057&ENST00000610538|c.617G>A|p.Gly206Asp|missense_variant|moderate|7|None|TP53|PF00870|True|False|False|False|protein_coding|917&ENST00000610623|c.257G>A|p.Gly86Asp|missense_variant|moderate|3|None|TP53|PF00870|True|False|False|False|protein_coding|558&ENST00000618944|c.257G>A|p.Gly86Asp|missense_variant|moderate|3|None|TP53|PF00870|True|False|False|False|protein_coding|543&ENST00000619186|c.257G>A|p.Gly86Asp|missense_variant|moderate|3|None|TP53|PF00870|True|False|False|False|protein_coding|698&ENST00000619485|c.617G>A|p.Gly206Asp|missense_variant|moderate|7|None|TP53|PF00870|True|False|False|False|protein_coding|1057&ENST00000620739|c.617G>A|p.Gly206Asp|missense_variant|moderate|7|None|TP53|PF00870|True|False|False|False|protein_coding|1057&ENST00000622645|c.617G>A|p.Gly206Asp|missense_variant|moderate|7|None|TP53|PF00870|True|False|False|False|protein_coding|902&ENST00000635293|c.617G>A|p.Gly206Asp|missense_variant_%26_NMD_transcript_variant|moderate|7|None|TP53|None|False|False|False|False|nonsense_mediated_decay|1225&NM_000546|c.734G>A|p.Gly245Asp|missense_variant|moderate|7|None|TP53|None|True|True|False|True|mRNA|1172&NM_001126112|c.734G>A|p.Gly245Asp|missense_variant|moderate|7|None|TP53|None|True|True|False|True|mRNA|1172&NM_001126113|c.734G>A|p.Gly245Asp|missense_variant|moderate|7|None|TP53|None|True|False|False|False|mRNA|1032&NM_001126114|c.734G>A|p.Gly245Asp|missense_variant|moderate|7|None|TP53|None|True|False|False|False|mRNA|1017&NM_001126115|c.338G>A|p.Gly113Asp|missense_variant|moderate|3|None|TP53|None|True|False|False|False|mRNA|779&NM_001126116|c.338G>A|p.Gly113Asp|missense_variant|moderate|3|None|TP53|None|True|False|False|False|mRNA|624&NM_001126117|c.338G>A|p.Gly113Asp|missense_variant|moderate|3|None|TP53|None|True|False|False|False|mRNA|639&NM_001126118|c.617G>A|p.Gly206Asp|missense_variant|moderate|6|None|TP53|None|True|False|False|False|mRNA|1057&NM_001276695|c.617G>A|p.Gly206Asp|missense_variant|moderate|7|None|TP53|None|True|False|False|False|mRNA|917&NM_001276696|c.617G>A|p.Gly206Asp|missense_variant|moderate|7|None|TP53|None|True|False|False|False|mRNA|902&NM_001276697|c.257G>A|p.Gly86Asp|missense_variant|moderate|3|None|TP53|None|True|False|False|False|mRNA|698&NM_001276698|c.257G>A|p.Gly86Asp|missense_variant|moderate|3|None|TP53|None|True|False|False|False|mRNA|543&NM_001276699|c.257G>A|p.Gly86Asp|missense_variant|moderate|3|None|TP53|None|True|False|False|False|mRNA|558&NM_001276760|c.617G>A|p.Gly206Asp|missense_variant|moderate|7|None|TP53|None|True|False|False|False|mRNA|1057&NM_001276761|c.617G>A|p.Gly206Asp|missense_variant|moderate|7|None|TP53|None|True|False|False|False|mRNA|1057;literature=26900293&26619011&25105660&1565143&17606709&20128691&21343334&12826609&2259385&17311302&21232794&11180592&25119136&12885464&18628487&30720243&11593407&11920788&23538418&24122735&22052707&7783166&32365829&1591732&34771529&30482293&28915716&36808708&15042566&33947685&31350822&17557566&19834951&28717136&26699864&31543384&36982875&26552420&22214764&30709875&32546937&36790396&28569743&32215186&26585234&32409749&32358561&26503331&27566247&29599920&30181556&27840695&17764544&27093186&28604612&24150215&35709138&28424415&30886117&28152038&25159915&32923890&30464253&33409278&28279041&26466571&28399885&29163793&29100312&30069017&31308060&23965983&30126368&23873848&31404346&27662657&28420421&29466950&28735817&29937994&32164171&28744014&30937429&32940377&28256603&32579932&26554728&34967917&29684080&26689913&28729728&28440963&23204232&27167113&26009992&30165392&35428753&35865001&30761385&37433786&26071483&30736836&32414156&32168400&29338072&31949278&27302369&26053092&32532965&31996390&30405107&29290998&21533174&25860607&23104009&33546769&21748247&27283993&27384348&34382365&32619037&26759717&30087719&27834926&26933808&28160562&31988276&27558455&32322110&28848703&20593220&31345222&31953485&27191893&27798105&29854298&27959900&26366557&32686686&24670820&29522538&23607916&28852847&23405175&34861696&37622400&29936259&29127303&31257224&26296973&28557976&21197471&37685923&31320741&29956783&26288819&31287991&35205822&25307848&25086664&30857943&28977883&35117791&36973285&28652265&24662767&26991344&34671345&29973234&26757882&30352134&29233927&22891273&22536974&26659599&33856277&29500184&26053404&24140581&27626278&36672294&33420073&30075702&31296311&28302137&1913660&18590527&27626311&23243591&32193378&24292195&35486574&29285234&26061684&25504633&25379706&26110843&36672377&27485054&25213837&36182938&32066459&28818333&28810143&24918944&25408419&26244006&28408749&27048880&30837681&26614708&29559732&29084603&27433916&24327102&29875142&8317895&26147798&30028779&33735664&32005111&32639993&35961859&26676230&28548104&34831372&31775766&27528217&27915290&35118119&28073006&36408368&31925297&32367667&29029427&35953718&30061624&31394872&28595259&29301828&25523272&29899852&26727500&30590044&31700061&25490524&29899868&25502816&35181666&31034466&34483300&25939062&29731965&31628423&25742471&31659152&31745173&31032472&29535388&26508446&32953503&30264478&25148578&29211816&19584170&26647728&27626691&25326804&27460824&29449433&30115035&29082853&25025766&28196074&27163884&24042735&37700856&30719225&29463802&35278076&23819521&24651012&33209609&27612425&21159183&29687062&30809375&31118664&22803791&29416795&28790110&26797410&37754227&19367287&33365374&27397505&20229506&32079237&34952583&29050249&27043212&32210335&25634208&34663841&30123427&29267365&34393517&37391803&37760445&19117505&30076358&31118792&28841418&34665935&28683746&34022887&26066407&31854063&24448499&34528763&31768066&31772163&28769798&33895946&27149842&32392735&34780712&25749039&27018799&25220666&30867008&33953347&37645893&31452755&26527317&28692054&37662293&37744220&25536104&25794154&29312620&25372287&33625734&31362708&19654296&29531804&25656989&10788533&30297788&26279620&33130194&31119060&23525077&25573078&25839328&30373609&24205039&32055024&34576114&33363700&30760703&26806015&25925381&30527243&24393486&28522256&30064409&27533082&30850842&24807215&26124082&30981944&35280700&23359294&27527004&30981987&21901162&29269868&21727090&30171025&29386642&31860648&25348012&32561076&27060149&30318520&36124629&31664085&27377626&35008477&28852190&29263839&29085664&28880866&21829606&24240112&34926584&29038591&37835402&37887543
